Patents by Inventor Matthew J. Taylor

Matthew J. Taylor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BENZOTHIOPHENE COMPOUNDS HAVING ANTIINFECTIVE ACTIVITY
    Publication number: 20090247513
    Abstract: Benzothiophene compounds such as are DNA binding compounds exhibiting antibacterial activity.
    Type: Application
    Filed: December 4, 2007
    Publication date: October 1, 2009
    Applicant: GeneSoft Pharmaceuticals, Inc.
    Inventors: Roland W. Burli, Eldon E. Baird, Matthew J. Taylor, Jacob A. Kaizerman, Wenhao Hu
  • Halogen-substituted thienyl compounds
    Patent number: 7498405
    Abstract: Halogen substituted thienyl compounds exhibit potential as nucleic acid (especially double stranded DNA) binders and as antibiotic compounds.
    Type: Grant
    Filed: June 2, 2006
    Date of Patent: March 3, 2009
    Assignee: GeneSoft Pharmaceuticals, Inc.
    Inventors: Yigong Ge, Matthew J. Taylor, Eldon E. Baird, Roland W. Burli, Jacob A. Kaizerman, Amanda E. Martin, Brie Cadman
  • Benzothiophene compounds having antiinfective activity
    Patent number: 7329765
    Abstract: Benzothiophene compounds such as are DNA binding compounds exhibiting antibacterial activity.
    Type: Grant
    Filed: November 30, 2004
    Date of Patent: February 12, 2008
    Assignee: GeneSoft Pharmaceuticals, Inc.
    Inventors: Roland W. Burli, Eldon E. Baird, Matthew J. Taylor, Jacob A. Kaizerman, Wenhao Hu
  • Charged compounds comprising a nucleic acid binding moiety and uses therefor
    Patent number: 7301037
    Abstract: Charged compounds are provided that comprise one or more regions of localized positive charge, compositions comprising such compounds, methods of synthesizing such compounds, methods of screening such compounds to identify those having anti-infective activity, and methods of using such compounds to prevent or inhibit infections. These compounds, and compositions containing them, have multiple applications, including use in human and animal medicine and in agriculture.
    Type: Grant
    Filed: July 14, 2006
    Date of Patent: November 27, 2007
    Assignee: Genesoft, Inc.
    Inventors: Yigong Ge, Matthew J. Taylor, Eldon E. Baird, Heinz E. Moser, Roland W. Burli
  • Halogen-substitued thienyl compounds
    Patent number: 7122626
    Abstract: Halogen substituted thienyl compounds exhibit potential as nucleic acid (especially double stranded DNA) binders and as antibiotic compounds.
    Type: Grant
    Filed: April 24, 2002
    Date of Patent: October 17, 2006
    Assignee: GeneSoft Pharmceuticals, Inc.
    Inventors: Yigong Ge, Matthew J. Taylor, Eldon E. Baird, Roland W. Bürli, Jacob A. Kaizerman, Amanda E. Martin, Brie Cadman
  • Charged compounds comprising a nucleic acid binding moiety and uses therefor
    Patent number: 7078536
    Abstract: Charged compounds are provided that comprise one or more regions of localized positive charge, compositions comprising such compounds, methods of synthesizing such compounds, methods of screening such compounds to identify those having anti-infective activity, and methods of using such compounds to prevent or inhibit infections. These compounds, and compositions containing them, have multiple applications, including use in human and animal medicine and in agriculture.
    Type: Grant
    Filed: October 22, 2002
    Date of Patent: July 18, 2006
    Assignee: Genesoft Pharmaceuticals, Inc.
    Inventors: Yigong Ge, Matthew J. Taylor, Eldon E. Baird, Heinz E. Moser, Roland W. Bürli
  • Benzothiophene compounds having antiinfective activity
    Patent number: 6825228
    Abstract: Benzothiophene compounds such as are DNA binding compounds exhibiting antibacterial activity.
    Type: Grant
    Filed: June 6, 2002
    Date of Patent: November 30, 2004
    Assignee: Genesoft Pharmaceuticals, Inc.
    Inventors: Roland W. Bürli, Eldon E. Baird, Matthew J. Taylor, Jacob A. Kaizerman, Wenhao Hu
  • BENZOTHIOPHENE COMPOUNDS HAVING ANTIINFECTIVE ACTIVITY
    Publication number: 20040142971
    Abstract: Benzothiophene compounds such as 1
    Type: Application
    Filed: June 6, 2002
    Publication date: July 22, 2004
    Applicant: GeneSoft, Inc.
    Inventors: Roland W. Burli, Eldon E. Baird, Matthew J. Taylor, Jacob A. Kaizerman, Wenhao Hu
  • Aryl-benzimidazole compounds having antiinfective activity
    Patent number: 6716866
    Abstract: Aryl-benzimidazole compounds according to the formula where Ar1, R1, R2, Y, W, and N are as defined herein, bind to DNA and have antibacterial activity.
    Type: Grant
    Filed: June 6, 2002
    Date of Patent: April 6, 2004
    Assignee: GeneSoft Pharmaceuticals, Inc.
    Inventors: Dustin L. McMinn, Roland W. Bürli, Jacob Kaizerman, Eldon E. Baird, Matthew J. Taylor
  • Charged compounds comprising a nucleic acid binding moiety and uses therefor
    Publication number: 20030211508
    Abstract: Charged compounds are provided that comprise one or more regions of localized positive charge, compositions comprising such compounds, methods of synthesizing such compounds, methods of screening such compounds to identify those having anti-infective activity, and methods of using such compounds to prevent or inhibit infections. These compounds, and compositions containing them, have multiple applications, including use in human and animal medicine and in agriculture.
    Type: Application
    Filed: October 22, 2002
    Publication date: November 13, 2003
    Applicant: Genesoft, Inc.
    Inventors: Yigong Ge, Matthew J. Taylor, Eldon E. Baird, Heinz E. Moser, Roland W. Burli
  • Aryl-benzimidazole compounds having antiinfective activity
    Publication number: 20030191168
    Abstract: Aryl-benzimidazole compounds according to the formula 1
    Type: Application
    Filed: June 6, 2002
    Publication date: October 9, 2003
    Applicant: GeneSoft, Inc.
    Inventors: Dustin L. McMinn, Roland W. Burli, Jacob Kaizerman, Eldon E. Baird, Matthew J. Taylor
  • Halogen-substitued thienyl compounds
    Publication number: 20030130198
    Abstract: Halogen substituted thienyl compounds exhibit potential as nucleic acid (especially double stranded DNA) binders and as antibiotic compounds.
    Type: Application
    Filed: April 24, 2002
    Publication date: July 10, 2003
    Applicant: GeneSoft, Inc.
    Inventors: Yigong Ge, Matthew J. Taylor, Eldon E. Baird, Roland W. Burli, Jacob A. Kaizerman, Amanda E. Martin, Brie Cadman
  • Charged compounds comprising a nucleic acid binding moiety and uses therefor
    Patent number: 6555693
    Abstract: Charged compounds are provided that comprise one or more regions of localized positive charge, compositions comprising such compounds, methods of synthesizing such compounds, methods of screening such compounds to identify those having anti-infective activity, and methods of using such compounds to prevent or inhibit infections. These compounds, and compositions containing them, have multiple applications, including use in human and animal medicine and in agriculture.
    Type: Grant
    Filed: March 14, 2001
    Date of Patent: April 29, 2003
    Assignee: Genesoft, Inc.
    Inventors: Yigong Ge, Matthew J. Taylor, Eldon E. Baird, Heinz E. Moser, Roland W. Bürli
  • Charged compounds comprising a nucleic acid binding moiety and uses therefor
    Publication number: 20020065227
    Abstract: Charged compounds are provided that comprise one or more regions of localized positive charge, compositions comprising such compounds, methods of synthesizing such compounds, methods of screening such compounds to identify those having anti-infective activity, and methods of using such compounds to prevent or inhibit infections. These compounds, and compositions containing them, have multiple applications, including use in human and animal medicine and in agriculture.
    Type: Application
    Filed: March 14, 2001
    Publication date: May 30, 2002
    Inventors: Yigong Ge, Matthew J. Taylor, Eldon E. Baird, Heinz E. Moser, Roland W. Burli
  • Stable beverages containing emulsion with unweighted oil and process of making
    Patent number: 5616358
    Abstract: The present invention relates to stable beverage products. The beverage products of the present invention comprise of an oil-in-water beverage emulsion which comprises an unweighted oil, water and a food grade stabilizer. The ratio of the stabilizer to the unweighted oil within the beverage emulsion is at least about 0.5:1. The mean particle size of the oil droplets present in the emulsion ranges from about 0.10 to about 0.30 microns. The particle size distribution of the oil droplets in the emulsion is such that less than about 3% (volume percent basis) of the particles have a particle size greater than about 0.39 microns and less than about 9% (volume percent basis) of the particles have a particle size of greater than about 0.34 microns The beverage products of the present invention further comprise a fruit juice and/or fruit or other flavor.
    Type: Grant
    Filed: July 19, 1995
    Date of Patent: April 1, 1997
    Assignee: The Procter & Gamble Company
    Inventors: Matthew J. Taylor, Paul R. Bunke, Phillip F. Pflaumer